HISTIDINE ATTENUATES CEREBRAL VASOSPASM IN A RABBIT MODEL OF SUBARACHNOID HEMORRHAGE

被引:29
|
作者
FADEL, MM
FOLEY, PL
KASSELL, NF
LEE, KS
机构
[1] UNIV VIRGINIA, DEPT NEUROL SURG, CHARLOTTESVILLE, VA 22908 USA
[2] UNIV VIRGINIA, VIRGINIA NEUROL INST, CHARLOTTESVILLE, VA USA
来源
SURGICAL NEUROLOGY | 1995年 / 43卷 / 01期
关键词
HISTIDINE; VASOSPASM; SUBARACHNOID HEMORRHAGE; FREE RADICAL SCAVENGER; RABBIT;
D O I
10.1016/0090-3019(95)80038-I
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND Free radical generation following hemolysis of a subarachnoid blood clot is believed to be a key component in the development of cerebral vasospasm. Histidine, an essential amino acid with free radical scavenging characteristics, was examined for its effects on cerebral vasospasm. METHODS An experimental rabbit model of subarachnoid hemorrhage-induced vasospasm was used in which autologous arterial blood was injected into the cisterna magna. Basilar arteries were removed following perfusion-fixation two days after the injection of blood, and their cross-sectional luminal areas were measured using computerized image analysis. Rabbits received intravenous injections of L-histidine or vehicle starting 30 min prior to induction of subarachnoid hemorrhage (SAH), with additional injections given four times per day for the next 2 days. RESULTS The luminal area of arteries from animals treated with histidine (50 mg/kg/dose or 100 mg/kg/dose) were significantly larger than those from vehicle-treated animals. Relative to the SAH-only groups (mean cross-sectional area = 106.8 x 10(3) mu m(2)), vasoconstriction was attenuated by 31% in the low dose treatment group (180.0 x 10(3) mu m(2)) and by 52% in the high dose treatment group (227.4 x 10(3) mu m(2)). Mean luminal area of control basilar arteries was 340.5 x 10(3) mu m(2). CONCLUSIONS These findings demonstrate that histidine reduces the amount of cerebral vasospasm occurring subsequent to experimental SAH. It is suggested that the free radical scavenging characteristics of histidine, particularly its ability to scavenge singlet oxygen, may be responsible for the reduction in vasospasm.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 50 条
  • [1] HISTIDINE ATTENUATES CEREBRAL VASOSPASM IN A RABBIT MODEL OF SUBARACHNOID HEMORRHAGE - COMMENTARY
    FINDLAY, JM
    SURGICAL NEUROLOGY, 1995, 43 (01): : 57 - 58
  • [2] Inhibitory effects of lidocaine on cerebral vasospasm in a rabbit model of subarachnoid hemorrhage
    Shi, Xianqing
    Ye, Baning
    Hu, Yuandong
    Wang, Yuhui
    Li, Jianquan
    Liao, Daqing
    Liu, Jin
    NEURAL REGENERATION RESEARCH, 2010, 5 (21) : 1657 - 1662
  • [4] Human tissue kallikrein ameliorates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage
    Mo Yunchang
    Dai Qinxue
    Ji Binbin
    He Xin
    Yang Lili
    Chen Linbi
    Geng Wujun
    Zhang Pengbo
    Wang Junlu
    NEUROLOGICAL RESEARCH, 2015, 37 (12) : 1082 - 1089
  • [5] Establishment of a new symptomatic cerebral vasospasm model following subarachnoid hemorrhage in rabbit
    施国君
    高国栋
    刘俊雄
    王敏
    中国临床康复, 2002, (01) : 134 - 135
  • [7] Penehyclidine hydrochloride attenuates cerebral vasospasm after subarachnoid hemorrhage
    Tang, Yan
    Chen, Xiaoyi
    Liu, Jin
    NEURAL REGENERATION RESEARCH, 2011, 6 (22) : 1725 - 1730
  • [8] Cilostazol attenuates cerebral vasospasm after experimental subarachnoid hemorrhage
    Nishino, Akio
    Umegaki, Masao
    Fujinaka, Toshiyuki
    Yoshimine, Toshiki
    NEUROLOGICAL RESEARCH, 2010, 32 (08) : 873 - 878
  • [9] The novel 5-lipoxygenase inhibitor ABT-761 attenuates cerebral vasospasm subarachnoid in a rabbit model of hemorrhage
    Barbosa, MD
    Arthur, AS
    Louis, RH
    MacDonald, T
    Polin, RS
    Gazak, C
    Kassell, NF
    NEUROSURGERY, 2001, 49 (05) : 1205 - 1212
  • [10] Rosiglitazone Attenuates Cerebral Vasospasm and Provides Neuroprotection in an Experimental Rat Model of Subarachnoid Hemorrhage
    Bo-Feng Lin
    Chan-Yang Kuo
    Li-Li Wen
    Chun-Mei Chen
    Ya-Feng Chang
    Chih-Shung Wong
    Chen-Hwan Cherng
    Mei-Yu Chuang
    Zhi-Fu Wu
    Neurocritical Care, 2014, 21 : 316 - 331